Cargando…

Firms’ participation in the Swiss COVID-19 loan programme

This paper analyses the determinants of firm participation in the Swiss COVID-19 loan programme, which aims to bridge firms’ liquidity shortfalls that have resulted from the pandemic. State-guaranteed COVID-19 loans are widely used by Swiss firms, with 20% of all firms participating, resulting in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuhrer, Lucas Marc, Ramelet, Marc-Antoine, Tenhofen, Jörn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094977/
https://www.ncbi.nlm.nih.gov/pubmed/33968811
http://dx.doi.org/10.1186/s41937-021-00070-4
_version_ 1783688010738434048
author Fuhrer, Lucas Marc
Ramelet, Marc-Antoine
Tenhofen, Jörn
author_facet Fuhrer, Lucas Marc
Ramelet, Marc-Antoine
Tenhofen, Jörn
author_sort Fuhrer, Lucas Marc
collection PubMed
description This paper analyses the determinants of firm participation in the Swiss COVID-19 loan programme, which aims to bridge firms’ liquidity shortfalls that have resulted from the pandemic. State-guaranteed COVID-19 loans are widely used by Swiss firms, with 20% of all firms participating, resulting in a sizeable programme of 2.4% of GDP. We use a comprehensive dataset to study the determinants of firm participation. Our results can be summarised as follows. First, participation was largely driven by the exposure of a firm to lockdown restrictions and to the intensity of the virus in the specific region. Second, we show that firms associated with lower liquidity ratios had a significantly higher probability of participating in the programme. Third, we find no clear evidence that firm indebtedness affected participation in the programme and no evidence that pre-existing potential “zombie firms” participated more strongly in the loan programme. Fourth, we show that the programme reached younger and smaller firms, which could be financially more vulnerable as they are less likely to obtain outside finance during a crisis. Overall, we conclude that given its objective, the programme appears to be successful.
format Online
Article
Text
id pubmed-8094977
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80949772021-05-05 Firms’ participation in the Swiss COVID-19 loan programme Fuhrer, Lucas Marc Ramelet, Marc-Antoine Tenhofen, Jörn Swiss J Econ Stat Original Article This paper analyses the determinants of firm participation in the Swiss COVID-19 loan programme, which aims to bridge firms’ liquidity shortfalls that have resulted from the pandemic. State-guaranteed COVID-19 loans are widely used by Swiss firms, with 20% of all firms participating, resulting in a sizeable programme of 2.4% of GDP. We use a comprehensive dataset to study the determinants of firm participation. Our results can be summarised as follows. First, participation was largely driven by the exposure of a firm to lockdown restrictions and to the intensity of the virus in the specific region. Second, we show that firms associated with lower liquidity ratios had a significantly higher probability of participating in the programme. Third, we find no clear evidence that firm indebtedness affected participation in the programme and no evidence that pre-existing potential “zombie firms” participated more strongly in the loan programme. Fourth, we show that the programme reached younger and smaller firms, which could be financially more vulnerable as they are less likely to obtain outside finance during a crisis. Overall, we conclude that given its objective, the programme appears to be successful. Springer International Publishing 2021-05-04 2021 /pmc/articles/PMC8094977/ /pubmed/33968811 http://dx.doi.org/10.1186/s41937-021-00070-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Fuhrer, Lucas Marc
Ramelet, Marc-Antoine
Tenhofen, Jörn
Firms’ participation in the Swiss COVID-19 loan programme
title Firms’ participation in the Swiss COVID-19 loan programme
title_full Firms’ participation in the Swiss COVID-19 loan programme
title_fullStr Firms’ participation in the Swiss COVID-19 loan programme
title_full_unstemmed Firms’ participation in the Swiss COVID-19 loan programme
title_short Firms’ participation in the Swiss COVID-19 loan programme
title_sort firms’ participation in the swiss covid-19 loan programme
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094977/
https://www.ncbi.nlm.nih.gov/pubmed/33968811
http://dx.doi.org/10.1186/s41937-021-00070-4
work_keys_str_mv AT fuhrerlucasmarc firmsparticipationintheswisscovid19loanprogramme
AT rameletmarcantoine firmsparticipationintheswisscovid19loanprogramme
AT tenhofenjorn firmsparticipationintheswisscovid19loanprogramme